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The complement system is composed of 11 plasma proteins that, together with 
proteins of the properdin system, constitute an important humoral effector of 
immunological  reactions  (1).  Several  native  serum  complement  (C)  proteins 
have been shown to consist of two or more covalently bound polypeptide sub- 
units.  These  include  Clq  (2),  C3  (3),  C4  (4),  C5  (3),  and  C8  (1).  Recently,  a 
precursor form of the fourth component of guinea pig C was identified in studies 
of the cell-free synthesis of C4 and in homogenates of liver (5). The precursor of 
C4 (pro-C4) is a single polypeptide chain of mol wt 200,000,  which is converted 
into native serum C4, a three chain protein of  similar molecular weight (4, 6). 
The possibility was considered that other multichain  C proteins were also 
synthesized as single chain precursors in analogy to pro-C4 and to other known 
precursor proteins such as proinsulin  (7).  In order to test this hypothesis,  we 
analyzed  the size and  subunit composition of the third component of C  (C3) 
synthesized in tissue culture and under cell-free conditions. 
Materials and Methods 
Phenylmethylsulfonylfluoride (PMSF), 1 reduced glutathione, HEPES,  GTP,  creatine phos- 
phokinase (CPK), phosphorylase A, and bovine serum albumin (BSA) were purchased from Sigma 
Chemical Co., St. Louis, Mo. ATP (dipotassium salt) and phosphocreatine (dipotassium salt) were 
from Calbiochem, La Jolla, Calif.  Ribonuclease-free sucrose and ovalbumin (OVA) were from 
Schwartz/Mann Div., Becton,  Dickinson and Co.,  Orangeburg, N.  Y. Tritiated leucine, 45 Ci/ 
mmol, and a 14C-labeled  I~amino acid mixture consisting  of equal amounts of 14C-leucine  (325 mCi/ 
retool), 14C-valine (251 mCi/mmol), 14C-isoleucine (321 mCi/mmol), and l~C-lysine (282 mCi/mmol) 
were obtained from New England Nuclear, Boston,  Mass.  Medium 199  (M-199), Medium 199 
Special (lacking valine, leucine, isoleucine, lysine, and glutamine), and glutamine were pur- 
chased from Microbiological  Associates,  Bethesda, Md.; fl-galactosidase and carbonic anhydraso 
from Worthington Biochemical  Corp.,  Freehold, N. J.; NCS solubilizer from Amersham/Searle 
Corp.,  Chicago,  Ill. 
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A ntisera.  The preparation of rabbit antiserum to guinea pig C3 (8) and of guinea pig antise- 
rum to OVA (6) has been described. Rabbit antiserum to BSA was purchased from Microbiological 
Associates.  The  globulin  fraction  of each  was  separated  from  antiserum  by  40%  (NH4)2 SO4 
precipitation  at  4°C  (30  min).  The  precipitate  was  dissolved  in  100  mM  KC1-50  mM 
Tris(hydroxymethyl)aminomethane  (Tris)  (pH 7.5)  (Tris-KC1 buffer), dialyzed against Tris-KCl 
buffer, and centrifuged (10,000 g) immediately before use. 
Liver Tissue Culture.  Short-term  cultures  of minced guinea  pig liver were established  by 
methods described in detail previously (6). Briefly, guinea pigs weighing approximately 200 g were 
killed and a portion of the liver immediately removed and placed in ice-cold M-199.  The liver was 
minced and washed, then 400 mg were incubated for 15 min at 37°C in M-199 Special. The medium 
was removed and replaced with M-199 Special containing glutamine, penicillin, and streptomycin 
plus 1.0 ml (100 ~Ci) of ~4C-labeled amino acids and the tissue fragments were incubated for 3-4 h 
at 37°C in a  humidified 5% CO2/95% air atmosphere.  The medium was then separated from the 
liver tissue by centrifugation and used as a source of extracellular (secreted) 14C-labeled  C3. 
Homogenization  of Liver Tissue.  After separation of the medium from the short-term tissue 
culture, the minced liver was washed with M-199. Then 400 mg of liver were homogenized in 8 ml 
of cold 0.5% sodium deoxycholate, 0.5% Triton X-100,  100 mM KC1, and 50 mM Tris-HC1 (pH 7.5) to 
which 80 t~l of 200 mM PMSF had been added (5). The homogenate was centrifuged (10,000 g) and 
the supernate was used as a  source of ~4C-labeled  intracellular C3. 
Guinea  Pig Liver S-20.  The preparation  of S-20,  a  source of polysomes and soluble factors 
required for protein synthesis, was described in detail previously (5). A guinea pig (approximately 
400 g) was killed, a portion of the liver removed and immediately placed in ice-cold homogeniza- 
tion buffer (0.250 M sucrose, 50 mM KC1, 5 mM MgCls, 3 mM glutathione, and 50 mM HEPES, pH 
7.3), rinsed several times, finely minced, and then homogenized in two volumes of the same buffer. 
The homogenate was centrifuged (8 min at 20,000 g) and the upper 4/5 of the supernate  (6.5 ml) 
was then applied to a  2  ×  35 cm Sephadex G-25  (coarse) column,  previously equilibrated with 
column buffer (homogenization buffer without sucrose) and fractions of 3 ml were collected. The 
four most turbid  fractions were pooled and  stored at  -90°C  in small aliquots.  This procedure 
requires the special precautions outlined in our previous paper (5) to minimize RNase activity. 
Cell-Free Synthesis of C3.  A portion of the S-20 preparation (0.6 ml) was incubated for 90 min 
at 25°C in a  mixture containing 5 mM MgC12, 100 mM KC1,  2 mM ATP, 0.5 mM GTP,  15 mM 
phosphocreatine, 10 t~g/ml CPK, 19 amino acids (40 ~M each) excluding leucine, 10 ~M 3H-leucine 
(500 ~Ci/ml), 1.8 mM reduced glutathione, and 30 mM HEPES (pH 7.3),  in a final vol of 1.0 ml in 
sterile  Brinkman  microfuge  tubes  (Curtin  Matheson  Scientific,  Inc.,  Medford,  Mass).  After 
incubation, an equal volume of a solution containing 1% deoxycholate, 1% Triton X-100,  6.7 mM 
leucine, 100 mM KC1, and 50 mM Tris HC1 (pH 7.5) was added to the incubation mixture followed 
by centrifugation at 100,000 g  for 2 h at 2°C to sediment polysomes. 
Assay of Total Protein Synthesis.  Samples of 5 ~l each were precipitated on Whatman 3 MM 
filter paper disks with TCA and counted in a Packard Tri-Carb Liquid Scintillation Spectrometer 
(Packard  Instrument  Co.,  Inc.,  Downers  Grove,  Ill.) following exactly  a  previously described 
procedure (5). 
Immunoprecipitation.  Purified guinea pig C3 (9) (330 ~g/ml), BSA (1 mg/ml), or OVA (0.5 mg/ 
ml) served as carriers for immunoprecipitation. Reaction mixtures were prepared containing 1.27 
~l C3, 1.6/~l BSA (or 8 ~1 OVA), 100 ~l of sample, and 95 ~tl 1% deoxycholate, 1% Triton X-100,100 
mM KC1, and 50 mM Tris-KC1 (pH 7.5).  The mixture was centrifuged (10,000g) then in separate 
tubes C3 was precipitated with 12.7  ~l anti-C3, the controls with 32 ~l anti-BSA (or 20 ~l anti- 
OVA). The amount of antibody was adjusted in each case to provide a twofold antibody excess and 
to yield a 30 ~g immune precipitate aftr 1 h incubation at room temperature. After washing, the 
immune precipitates were either dissolved in NCS and counted in a liquid scintillation spectrome- 
ter,  or they were dissolved and  separated  on sodium dodecyl sulfate  (SDS)-polyacrylamide gel 
electrophoresis (PAGE), as described below. 
SDS-PAGE.  The procedure according to Fairbanks et al. (10) for the preparation and electro- 
phoresis of 5.6% polyacrylamide-l% SDS gels was followed. Immune precipitates were dissolved in 
SDS buffer, boiled, and electrophoresed as previously described (5). To assay radiolabeled protein, 
the gels were sliced into 2-mm segments, each placed in scintillation vials, and incubated with 1 
ml of a  NCS-toluene mixture  (1:1) at 45°C for 18 h.  Then 10 ml of scintillation fluid (0.5%  2,5- 
diphenyloxazole and 0.01% p-bis(2-(5°phenyloxazolyl))-benzene in toluene) was added,  the vials VOLKER  BRADE,  ROBERT  E.  HALL,  AND  HARVEY  R.  COLTEN  761 
were cooled and stored for 24 h  at 4°C, and radioactivity counted by scintillation spectrometry. 
Parallel gels with standard molecular weight markers were run and stained with Coomassie Blue. 
Markers were human spectrin (a gii%  from Dr. S. Lux, Children's Hospital Medical Center, Boston, 
Mass.),  B-galactosidase, phosphorylase A, BSA, OVA, and carbonic anhydrase.  Plotting of stan- 
dard curves was done according to Weber and Osborn (11), using mol wt of 220,000  and 240,000 for 
spectrin. 
Results 
Medium harvested from short-term cultures contained hemolytically active 
C3  at a  concentration of about 3.0  x  l0  s effective molecules/ml. Of the total 
protein secreted by the liver (TCA  precipitable,  40,000 cpm/100  /~l material) 
approximately 6% (2,300 cpm) was specifically precipitated by antiserum to C3. 
This amount was significantly greater than the proportion of C3 to total protein 
detected intracellularly or under cell-free conditions. That is, approximately 1% 
(500 cpm) of the total intracellular radiolabeled protein (54,000 cpm) and 0.2% 
(4,000 cpm)  of total  protein  (1,800,000  cpm)  synthesized and  released from 
polyribosomes under cell-free conditions was precipitated by antiserum to C3. 
Extracellular 14C-labeled C3, secreted by liver fragments in culture, migrated as 
a single peak on SDS-PAGE in the absence of reducing agent (dithiothreitol) 
(Fig. 1 A). As estimated from standard markers, it had an apparent mol wt of 
180,000 daltons (average of three experiments). Radiolabel in the control immu- 
noprecipitates distributed uniformly  throughout the gels. Under reducing condi- 
tions, C3 secreted by the liver fragments dissociated into two subunits of mol wt 
120,000 and 76,000 (Fig.  1 B).  Medium from starch-induced peritoneal macro- 
phage cultures secreted hemolytically  active C3 of size and subunit composition 
similar to that secreted by liver (data not shown). 
Analysis on SDS-PAGE of intracellular C3, obtained from the liver homoge- 
nate, revealed a  single peak of radioactivity under reducing conditions (Fig. 
2 A). Its size was estimated to be about 170,000 daltons. Under cell-free condi- 
tions, newly synthesized C3 also had an approximate mol wt of 170,000 and its 
mobility was unchanged in the presence of dithiothreitol (Fig. 2 B). In addition 
to the major peak of 170,000 daltons, a small amount of radiolabeled material 
was present in the 70,000-40,000 dalton region. 
In order to directly compare the size of intact C3 secreted by liver in culture 
with C3 synthesized under cell-free conditions, the cell-free product (3H labeled) 
and culture medium (14C labeled) were immunoprecipitated, the precipitates 
washed, and then mixed and subjected on the same gel to SDS-PAGE under 
nonreducing conditions. The results (Fig. 3) showed that they were of identical 
molecular size. 
Discussion 
Earlier reports indicated that C3 is synthesized in liver (12-14) and cells of  the 
macrophage/monocyte  series (15-17).  2 In addition, it was shown that C3 secreted 
by human monocytes in culture has a molecular weight and subunit composition 
similar to that of native human serum C3; i.e. consists of two polypeptide chains 
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Fro.  1.  SDS-PAGE  of immunoprecipitates of liver tissue culture medium: (A) anti-C3, 
anti-BSA; absence  of  reducing agent [dithiothreitol (DTT)]; (B) anti-C3, anti-BSA;  presence 
of 50 mM DTT. 
of mol wt 118,000 and 77,000. 2 In the present report, the corresponding guinea 
pig protein secreted in both liver and peritoneal macrophage cultures was found 
to have a similar size and subunit structure. In contrast, intracellular C3 from 
liver homogenates and C3 synthesized under ceil-free conditions consisted of a 
single polypeptide chain suggesting that C3  is synthesized and released from 
polysomes as a precursor (pro-C3). In this respect, the synthesis of both C3 and 
C4 (5) appear to be similar. 
The conversion of proinsulin to insulin is the result of excision of a relatively 
large molecular weight poptide leading to a  significant difference in size be- 
tween the precursor and insulin itself (18). Similar observations have been made 
in the case of several other precursor proteins (19-22).  With regard to pro-C4 or 
pro-C3  and  their  respective  extracellular  native  products  (C4  and  C3),  no 
significant loss of material apparently occurs in conversion of the precursor to 
the native protein. In fact, pro-C4 is slightly smaller than C4, possibly due to a VOLKER  BRADE,  ROBERT  E. 
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FIG.  2.  SDS-PAGE of immunoprecipitates: (A) liver homogenate (intracellular material); 
anti-C3, anti-BSA in the presence of 50 mM [dithiothreitol DTT]; (B) products of cell-free 
protein synthesis, released from polysomes; anti-C3, anti-OVA in presence of 50 mM DTT. 
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FIG.  3.  SDS-PAGE.  Anti-C3 immunoprecipitates of cell-free products  (3H-labeled) were 
combined with anti-C3 immunoprecipitate of liver tissue culture medium (14C-labeled) and 
electrophoresed in the absence of dithiothreitol in the same gel, then sliced and counted 
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difference in  carbohydrate  content.  These  data  are  most consistent  with  the 
hypothesis that conversion of pro-C3 or pro-C4 to the native extracellular pro- 
teins does not require excision of a large peptide, but the total sizes of these pre- 
cursor proteins and the relative imprecision of the estimates of molecular weight 
preclude a  definitive conclusion at the present time. 
Conversion of pro-C3 to C3 is similar to conversion of Cls to its active form, 
CI~  (23)  or  prothrombin  to  thrombin  (24).  For  instance,  evidence  has  been 
presented  that  activation  of Cls  (the  zymogen)  to  CI~  (the  active  esterase) 
results  from limited  proteolysis,  converting  a  single  chain  molecule  (Cls)  to 
one with two chains linked by a disulfide bridge (CI~). Cls circulates in plasma 
in the C1 complex, but thus far no evidence for extracellular pro-C3 or pro-C4 (5, 
6) has been obtained. Instead, C3 and C4 circulate as multichain proteins which 
require still further cleavage to generate biologically active proteins  (1). 
Evidence  has  been  obtained  that  the  light  and  heavy  chains  of gamma 
globulin  are  synthesized  separately  and  then  assembled  to  form  the  native 
molecule (25).  The finding of single chain precursor proteins for C3 and C4 (5) 
raises the possibility that post-translational  assembly of polypeptide subunits 
does not occur in production of other multichain  C components. Studies of cell- 
free synthesis, as well as tissue culture methods, will make it possible to test the 
validity of this conclusion. 
Summary 
A  precursor of the third  component of complement, pro-C3,  was detected in 
studies of cell-free synthesis and intracellularly in homogenates of liver tissue 
cultures.  The  molecular weight of pro-C3 was indistinguishable  from that  of 
intact native  C3 secreted in vitro by liver or peritoneal  macrophages,  but its 
structure  was  different.  Pro-C3  is  a  single  polypeptide  chain,  whereas  C3 
secreted by cells in culture consists of two polypeptide chains  (mol wt 120,000 
and 76,000)  linked by disulfide bonds. 
Received for publication 11 May 1977. 
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